Patents by Inventor Gail Bishop

Gail Bishop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10092635
    Abstract: The present invention provides a therapeutic agent comprising an antibody-recognition epitope (ARE) covalently bound to a tumor cell, wherein the ARE is bound to an antibody that is specific for the ARE, to form a tumor cell:ARE:antibody complex, and kits and methods of using these tumor cell:ARE:antibody complexes.
    Type: Grant
    Filed: January 30, 2014
    Date of Patent: October 9, 2018
    Assignee: University of Iowa Research Foundation
    Inventors: Tony Vanden Bush, Gail Bishop
  • Patent number: 10059746
    Abstract: The present invention provides a process called “Immune Banking” that enhances vaccine efficacy by exploiting existing humoral responses. The process involves tagging new antigens with molecular markers recognized by an existing antibody response. This recognition of the tagged vaccine components enhances adaptive immune responses to the new vaccine.
    Type: Grant
    Filed: April 4, 2012
    Date of Patent: August 28, 2018
    Assignee: University of Iowa Research Foundation
    Inventors: Gail Bishop, Tony Vanden Bush
  • Publication number: 20180055920
    Abstract: The present invention provides a method of preparing an anti-cancer composition comprising activated immune cells and a pharmaceutically acceptable excipient. The present invention further provides a method of contacting immune cells obtained from an animal with an optimal combination of activating agents and with an immunogenic material to form the activated immune cells.
    Type: Application
    Filed: March 11, 2016
    Publication date: March 1, 2018
    Applicant: UNIVERSITY OF IOWA RESEARCH FOUNDATION
    Inventor: Gail Bishop
  • Publication number: 20150374809
    Abstract: The present invention provides a therapeutic agent comprising an antibody-recognition epitope (ARE) covalently bound to a tumor cell, wherein the ARE is bound to an antibody that is specific for the ARE, to form a tumor cell:ARE:antibody complex, and kits and methods of using these tumor cell:ARE:antibody complexes.
    Type: Application
    Filed: January 30, 2014
    Publication date: December 31, 2015
    Applicant: UNIVERSITY OF IOWA RESEACH FOUNDATION
    Inventors: Tony Vanden Bush, Gail Bishop
  • Publication number: 20140134204
    Abstract: The present invention provides a process called “Immune Banking” that enhances vaccine efficacy by exploiting existing humoral responses. The process involves tagging new antigens with molecular markers recognized by an existing antibody response. This recognition of the tagged vaccine components enhances adaptive immune responses to the new vaccine.
    Type: Application
    Filed: April 4, 2012
    Publication date: May 15, 2014
    Applicant: UNIVERSITY OF IOWA RESEARCH FOUNDATION
    Inventors: Gail Bishop, Tony Vanden Bush
  • Publication number: 20120195926
    Abstract: The present invention provides a process called “Immune Banking” that enhances vaccine efficacy by exploiting existing humoral responses. The process involves tagging new antigens with molecular markers recognized by an existing anti-body response. This recognition of the tagged vaccine components enhances adaptive immune responses to the new vaccine.
    Type: Application
    Filed: October 1, 2010
    Publication date: August 2, 2012
    Applicant: UNIVERSITY OF IOWA RESEARCH FOUNDATION
    Inventors: Gail Bishop, Tony Vanden Bush
  • Publication number: 20040170614
    Abstract: The present invention provides vectors for gene targeting and disruption in somatic cells, and methods for using the same.
    Type: Application
    Filed: October 27, 2003
    Publication date: September 2, 2004
    Inventors: Gail Bishop, Bruce S. Hostager